AEX-1: A Vero cell variant with enhanced permissiveness for influenza virus replication

This publication has 28 references indexed in Scilit:

• Protective efficacy of the UniFluVec influenza vaccine vector against the highly pathogenic influenza A/Indonesia/5/2005 (H5N1) strain in ferrets
  Vaccine, 2025
• Cell-Based Quadrivalent Inactivated Influenza Virus Vaccine (Flucelvax® Tetra/Flucelvax Quadrivalent®): A Review in the Prevention of Influenza
  Drugs, 2019
• Potential neoplastic evolution of Vero cells: in vivo and in vitro characterization
  Cytotechnology, 2017
• Egg‐ or cell culture‐derived hemagglutinin mutations impair virus stability and antigen content of inactivated influenza vaccines
  Biotechnology Journal, 2013
• Comparison of initial feasibility of host cell lines for viral vaccine production
  Journal of Virological Methods, 2013
• Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: Homologous or heterologous booster response following two dose or single dose priming
  Vaccine, 2012
• Mutations affecting the stability of the haemagglutinin molecule impair the immunogenicity of live attenuated H3N2 intranasal influenza vaccine candidates lacking NS1
  Vaccine, 2011
• MDCK and Vero cells for influenza virus vaccine production: a one-to-one comparison up to lab-scale bioreactor cultivation
  Applied Microbiology and Biotechnology, 2010
• Distinct host range of influenza h3n2 virus isolates in vero and mdck cells is determined by cell specific glycosylation pattern
  Virology, 2003
• Apoptosis by influenza viruses correlates with efficiency of viral mRNA synthesis
  Virus Research, 2001